Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Palivizumab Product Approval Information - Licensing Action

Proper name: Palivizumab
Tradename: Synagis
Manufacturer: MedImmune, Inc, Gaithersburg, MD, License #1252
Revise Package Insert: Revise Warnings and Adverse Reactions sections to include anaphylaxis and to revise the Immunogenicity subsection
Approval Date: 10/23/2002
Type of submission: Biologics license application supplement


Approval Letter (PDF)

Label (PDF)

Page Last Updated: 10/04/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English